Never a dull moment in the risky Biotech arena. The amazing number of actions taken and that are underway tells me that this is a dynamic company that has had their share of missteps but will soon have a huge cash pool and a huge revenue stream.
Those that were hoping that the good ship Elan was going to join the Titanic will be disappointed. The third rise of the Phoenix from the ashes is underway.